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D
isruptive nocturnal behaviors (DNB) consisting of excessive movements, autonomic hyperarousal, abnormal vocalizations and complex motor behaviors, and nightmares which are replays of traumatic experiences are frequently reported sleep disturbances in combat veterans and trauma survivors with and without posttraumatic stress disorder (PTSD). [1] [2] [3] [4] [5] [6] Despite their frequent occurrence, there is no established diagnosis that accurately encompasses these sleep disturbances. Lack of diagnostic criteria is likely secondary to the discrepancy between frequent self-reported DNB and the rare occurrence of DNB in laboratory settings. 1, 7, 8 Thus, the exact nature of DNB in terms of their sleep stage, electromyographic (EMG) characteristics, and physiologic parameters are relatively unknown.
Nightmare disorder is reported in up to 80% of patients with PTSD. 9 This diagnosis does not acknowledge the presence of the DNB that trauma survivors frequently report. 2, 4, 9 Secondary REM behavior disorder is reported to occur in patients with PTSD when REM without atonia (RWA) is present on a polysomnogram (PSG) and dream enactment behaviors are reported or are present on PSG 4, 10 ; however, the onset of DNB and nightmares after an inciting traumatic event and the autonomic hyperactivity reported with trauma associated sleep disturbances are clinical and physiologic abnormalities that are not associated with REM behavior disorder (RBD). [11] [12] [13] The inimitable We report 4 cases of trauma associated sleep disturbances in young active duty U.S. Army soldiers with DNB and nightmares and corresponding PSG fi ndings. This case series illustrates that there is no current diagnosis which accurately encompasses the distinct clinical characteristics, PSG fi ndings, and treatment responses among trauma survivors with DNB and nightmares. We, thus, propose a new diagnostic term, Trauma associated Sleep Disorder (TSD), and review the evidence that supports the hypothesis that this condition may represent a unique trauma related parasomnia.
BRIEF SUMMARY
Current Knowledge/Study Rationale: Disruptive nocturnal behaviors and nightmares are frequently reported by trauma survivors and their spouses but rarely documented in laboratory settings. There is no current diagnosis which encompasses these trauma engendered sleep disturbances. Study Impact: This series of patients describes the clinical, PSG and treatment responses of patients with trauma associated sleep disturbances. Trauma associated sleep disorder (TSD) is likely a new sleep disorder which can facilitate evaluation and treatment of patients with this constellation of fi ndings.
CASE HISTORIES
All patients were young men, active duty U.S. Army soldiers, who presented with DNB and nightmares. In each case, the patient reported no sleep disturbances or parasomnias prior to their traumatic experiences. Clinical evaluations occurred in our sleep medicine clinic following referral from either primary care or behavioral health. An attended PSG with video monitoring was performed on each patient in accordance with American Academy of Sleep Medicine standards. 16 All REM epochs were reviewed by two physicians, board certified in sleep medicine, who assessed the videos for any movements or vocalizations. RWA was quantified utilizing "any" surface EMG activity of the mentalis muscle, according to previously established methods by the SINBAR group and subsequently reported by Sixel-Döring et al. 17, 18 
Patient 1
A 29-year-old with combat-related PTSD, insomnia, depression, and alcohol abuse in remission reported sleep disturbances following a 6-month combat-deployment to Afghanistan in 2010. Approximately 12 months after returning home, he developed DNB and nightmares. The DNB consisted of screaming and combative movements. In his nightmares, assailants pursued and threatened him. His medications were paroxetine 30 mg daily for depression; prior to bed he took trazodone 50 mg for insomnia and prazosin 6 mg for nightmares. He reported some medication non-adherence, but when taking prazosin he had less frequent DNB and nightmares. The DNB and nightmares preceded all medication use. His PSG was conducted 18 months after nightmare and DNB onset. On the night of the PSG, the patient took trazodone 50 mg but failed to take his usual dose of prazosin. Figure 1 depicts a 30-sec epoch of sleep from his early onset REM period. The patient initially had REM with atonia; 34 sec after REM onset, RWA is observed with augmented chin EMG tone and phasic limb movements. Video monitoring documented vocalizations (he repeatedly yelled "oh f***, leave me alone!") and defensive limb movements (primarily upper extremity). Tachypnea and tachycardia were associated with his vocalizations. His "any" EMG activity index was 17.6%. Upon completion of the study he recalled a combat-related nightmare, characteristic of his usual nightmares. At clinical follow-up, treatment with image rehearsal therapy (IRT) and cognitive behavioral therapy for insomnia (CBTi) was discussed. He was advised to continue prazosin and implement safe sleeping practices. He was discharged from the Army and did not pursue further medical care.
Patient 2
A 34-year-old with adjustment disorder, anxiety, insomnia, and symptoms of snoring and witnessed apneas reported sleep disturbances following a 12-month combat-deployment to Iraq in 2003. Upon return from this deployment, he developed difficulties falling and staying asleep; nightmares and night sweats a "Any" EMG activity index was measured as "any" activity on mentalis muscle EMG per 3-sec mini-epoch and then calculated as percent of total REM. BMI, body mass index; SSRI, selective serotonin reuptake inhibitors; PTSD, posttraumatic stress disorder; ESS, Epworth Sleepiness Scale; ISI, Insomnia Severity Index; WASO, wakefulness after sleep onset; REM, rapid eye movement; AHI, apnea hypopnea index; PLMS, periodic limb movements of sleep.
started a few months after returning home. He had 2 subsequent deployments and then developed DNB. His DNB consisted of thrashing movements and one episode of choking his wife. Following this violent nocturnal behavior, the patient slept separately from his wife as she feared for her safety. Nightmares involved combat-related experiences. At the time of his sleep evaluation he was taking no medications. His PSG was conducted 11 years after nightmare onset and 6 months after DNB onset. No DNB observed, and the "any" EMG activity index was 13.7%. At clinical follow-up he was treated with CBTi for his insomnia and auto-titrating positive airway pressure (APAP) therapy for mild OSA. For DNB and nightmares he was started on prazosin 30 minutes prior to bedtime and advised to implement safe sleeping practices. Approximately 2 months after starting prazosin at a dose of 4 mg, he had complete resolution of his DNB and nightmares, well-treated OSA with adherence to APAP, and overall improved sleep quality. His wife felt safe with him and they resumed sleeping in the same bed.
Patient 3
A 39-year-old with no significant medical history, but with symptoms of loud, bothersome snoring reported sleep disturbances following a 12-month combat-deployment to Iraq in 2007. His spouse alerted him to DNB which consisted of somnambulism, somniloquy, and combative behaviors of kicking and punching. During these episodes his wife described he looked like he was fighting someone. She reported being struck several times over the years, with one violent nocturnal event that resulted in bruising to her face. This prompted both individuals to seek treatment and the spouse to sleep in a separate room. His nightmares were vague flashbacks to a combat environment with little dream recall upon awakening. His PSG was conducted 6 years after nightmare and DNB onset. No DNB observed, and the "any" EMG activity index was 37.6%. The patient was started on prazosin for DNB and nightmares and APAP for mild OSA. Initially he reported decreased DNB and nightmares with 4 mg prazosin, and his sleep was more restorative. Prazosin was titrated to 12 mg as his DNB persisted in the setting of difficulties with APAP adherence.
Patient 4
A 22-year-old presented with symptoms of snoring, nocturnal dyspnea, witnessed apneas, and daytime somnolence. He had never deployed but had a traumatic relationship and breakup with a fiancée. Two months after this experience he developed nightmares and DNB. His nightmares occurred almost every night and were related to this relationship. He reported DNB consisting of "screaming, crying, throwing pillows, and cursing" with a witnessed episode where a roommate reported him punching and kicking a wall screaming "I am going to kill you." His new bed partner frequently had bruises and disrupted sleep due to his DNB. After his symptoms started, he was diagnosed with generalized anxiety disorder and treated with sertraline 50 mg. His anxiety improved, but his nightmares and DNB persisted. His PSG was conducted 12 months after symptom onset. No DNB observed, and the "any" EMG activity index was 14.8%. For treatment of mild OSA, APAP was initiated and his sleep disordered breathing and sleepiness resolved with adherence to therapy. His DNB and nightmares persisted, and he was treated with prazosin. At 5 mg his DNB and nightmares completely resolved; however, he had side effects of sleep paralysis and lightheadedness. This resulted in him stopping the prazosin with return of his nightmares and DNB. At 3 mg his nightmares occurred once weekly with resolution of DNB.
DISCUSSION
This case series reports 4 young male active duty soldiers, with and without PTSD, all with traumatic experiences heralding the onset of DNB and nightmares. All patients had RWA with one patient's PSG capturing a rare in-laboratory nightmare with loud vocalizations, body movements, and sympathetic surges as evidenced by tachypnea and tachycardia. These soldiers are prototypical of the combat veterans seen throughout Department of Defense Medical Treatment Facilities, where there has been a marked increase in the diagnoses of night terrors, nightmare disorder, somnambulism, and RBD. Typically these diagnoses are rendered clinically without PSG documentation. We propose TSD to encompass the complex DNB and nightmares frequently reported, but rarely documented in combat veterans and trauma survivors.
The characteristic PSG finding of TSD is RWA which was present in all of our patients. The patients we report had "any" EMG activity index values ranging from 13.7% to 37.6% utilizing the conventional 3-second mini-epoch scoring. Only patient 3 had an "any" EMG activity index that exceeded the cutoff for both RBD and the 95 th percentile of healthy normal reported by the SINBAR group and Frauscher et al. 17, 19 The nature of our report limits our ability to propose an "any" EMG activity index cutoff value for TSD. However, as the majority of our patients had normal values for their "any" EMG activity index, a normal index does not necessarily exclude TSD.
In a study of Vietnam veterans with long-standing PTSD, Ross et al. reported the finding of increased phasic lower extremity EMG tone in REM. 15 More recently, Wallace et al. reported REM behavior disorder in 4 recent veterans of Operations Iraqi Freedom and Enduring Freedom, all of whom were taking selective serotonin reuptake inhibitors (SSRI) at the time of their PSG. 4 From this, it appears that RWA may occur more frequently than has been reported in trauma survivors. RWA and dream enactment behaviors have rarely been documented on PSG. 3, 6 In these reports the PSG was typically performed early after the traumatic event.
7 This is consistent with our Defense of the sleeper against attack 20 Disruptive nocturnal behaviors Recorded in REM and NREM 2, 6 Thrashing movements Startle/panic-like awakenings 1, 2, 6 Acting out dreams Rarely recorded in sleep lab 6, 7, 21, 22 Exclusive to REM 11, 20 Acting out dreams with combative, injurious behaviors 12 Frequently recorded in sleep lab 20 Associated illnesses Post-traumatic stress disorder 2, 3 Parkinson's disease Lewy Body Dementia Multiple system atrophy Narcolepsy 14, 20 PSG characteristics Altered REM latency 5, 21 REM sleep without atonia 2, 3, 21, 22 "Any" EMG activity index may be normal to increased
Normal REM latency REM sleep without atonia 12, 20 "Any" EMG activity index > 18.2% findings, noting that only patient 1 had DNB and nightmare capture during a PSG. The findings we report could be interpreted as secondary RBD. However, the clinical characteristics, PSG findings, and responses to treatment support this as a unique sleep disorder ( Table 2) . Patients with TSD are young males as opposed to patients with RBD who are typically elderly males, many whom have an associated synucleinopathy. 12, 14, 20 In RBD, the onset is insidious, occurring without a precipitating event. 12, 20 This contrasts with TSD, where there is a traumatic experience that heralds the onset of DNB and nightmares. In RBD the nightmares develop as part of the disorder, whereas in TSD the nightmares are a replay of the traumatic experience. 2, 3, 6, [20] [21] [22] The other feature is the nightmares of RBD tend to have similar themes of self-defense or fending off animals, while the nightmares of TSD are unique to each patient. 4, 20 Many soldiers and their spouses report injuries secondary to DNB, resulting in them sleeping separately to avoid harm. They are surprised when their sleep studies do not document DNB. Lack of DNB capture during PSG despite nightly symptoms at home has been reported in military and non-military PTSD patients. 1, 7, 21, 22 In patients with RBD, dream enactment behaviors are frequently documented in laboratory settings.
12,20 A potential reason for lack of PSG documentation of DNB in trauma survivors is the sleep laboratory alters their habitual sleep ritual and the monitored environment is perceived as safe.
The sympathetic activation documented in patient 1, reported by our patients, along with findings in previous trauma survivors during REM sleep, is unique to TSD. 13, 15, 22 In descriptions of RBD by Mahowald and Schenk, there is absence of autonomic reactivity in RBD, specifically the lack of tachycardia despite vigorous limb movements.
11,12 REM sleep is characterized by marked suppression of sympathetic tone which "may be one of the most fundamental and functionally important aspects of this state." 23 Thus, in TSD there appears to be an overdrive phenomenon, which results in loss of REM atonia and sympathetic suppression.
Two patients we report were taking SSRI, which may have contributed to their RWA. SSRI are associated with early-onset RBD which can persist even after discontinuing the medication. 24, 25 A recent study by Lam et al. concluded that RWA in patients with psychiatric disorders was a complex interaction between their disorder and psychoactive medications, not solely a medication side effect. 24 Similar to classic RBD, the sleep disturbances in these patients lacked an inciting traumatic event and the traumatic dream replay of TSD. In addition, our patients reported DNB and nightmares prior to initiation of SSRI therapy, making it less likely the etiology of their disorder. The findings by Lam et al. while differing from TSD, support clinical differentiation of patients with RWA co-occurring with psychiatric disorders from RBD.
In the soldier that had his DNB and nightmare captured, this potentially occurred due to lack of prazosin dosing the night of his PSG. Prazosin, an α 1 -adrenergic receptor antagonist has documented efficacy in treating nightmares in PTSD.
9,26 Prazosin and IRT are the recommended treatments for patients with PTSD-associated nightmares. 26, 27 We are unaware of any reports of these treatments in specifically ameliorating the DNB that can occur with PTSD; however, in their landmark prazosin study, Raskind et al. viewed PTSD nightmares as associated with motor activity. 26 Clonazepam is the accepted therapy for RBD, 11, 20 and a report of 3 patients with apparent longstanding TSD suggested some efficacy. 10 A small placebo-controlled study showed clonazepam had no efficacy in patients with findings consistent with TSD. 28 All the patients we report had clinical improvement with prazosin. Patients 1 and 4 reported return of DNB and nightmares with discontinuation of prazosin. Patients 2 and 4 underwent a follow-up PSG on prazosin and CPAP when their sleep improved. Patient 2 had an "any" EMG activity index of 12.1% and patient 4 an index of 19.3%. These findings suggest that while prazosin ameliorates clinical symptoms it does not necessarily alter the underlying mechanism of RWA, as neither patient's "any" EMG activity index substantially changed. In addition to prazosin, we recommend patients with TSD receive counseling regarding safe sleeping practices and a sleep medicine consultation to evaluate for other sleep disorders. As all of the patients had insomnia and 3 had OSA, treatment of these comorbid sleep disorders likely contributed to their improved sleep.
In our experience, approximately 50% of patients with TSD will have PTSD, while the other half will exclusively manifest the nocturnal symptoms of DNB and nightmares. Neuropathologically, RBD has been associated with loss of noradrenergic neurons of the locus ceruleus and/or peri-locus ceruleus, 10 whereas PTSD appears to be characterized by hyper-adrenergic function of these areas. 2, 10 Blockade of the hyper-adrenergic function is thought to be the primary mechanism of action of prazosin. 26 There are positron emission tomography (PET) studies that document neural characteristics differentiating RBD and PTSD. These findings may help further explain the clinical differences between RBD and TSD. Cerebral hypometabolism in occipitoparietal, paralimbic, and anterior temporal cortices has been reported on PET scans of patients with RBD 29, 30 In a study of combat-related PTSD with patients who reported DNB, cerebral hypermetabolism was detected in brainstem regions, such as the midbrain reticular formation, locus ceruleus, and the pedunculopontine tegmentum, as well as regions involved in the threat response (e.g., amygdala, dorsal cingulate, and hippocampus) during wakefulness and REM sleep. 31 Hyperactivity in these neuroanatomical regions during REM may result in RWA and DNB, including dream enactment behaviors.
The present case series and review of sleep disturbances associated with trauma summarizes the features of TSD along with proposed diagnostic criteria ( Table 3 ). The patients we report have multiple factors that potentially contribute to changes in neural modulation of REM atonia and trigger dream enactment. A traumatic experience incites this disorder with contributions from chronic stress, psychiatric and comorbid sleep disorders, and antidepressant use either independently or synergistically facilitating RWA. Our patients' clinical improvement with central noradrenergic blockade suggests prazosin partially normalizes the modulation of REM atonia and may have a role in the treatment of both TSD and RBD. With increasing evidence of an association between trauma and REM sleep pathology, there is a requirement for additional research, which could be wellserved by a clinical registry for trauma survivors, to further establish the characteristics of TSD.
